Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Scorpius Holdings Inc SCPX

Healthcare Biotechnology
Scorpius Holdings, Inc., formerly NightHawk Biosciences, Inc., is an integrated contract development and manufacturing company. The Company is focused on advancing biologic and cell therapy programs to the clinic and beyond. It offers a broad array of analytical testing, process development, and manufacturing services to pharmaceutical and biotech companies at its facilities in San Antonio... see more

Recent & Breaking News (NYSEAM:SCPX)

Heat Biologics Announces Suspension of Proposed Public Offering of Common Stock

GlobeNewswire July 22, 2016

Heat Biologics Announces Proposed Public Offering of Common Stock

GlobeNewswire July 21, 2016

Heat Biologics Announces “Cancer Immunology Research” Publication Featuring its ComPACT Platform Technology

GlobeNewswire July 7, 2016

Biotechnology Equities at a Glance -- MannKind, bluebird bio, OncoGenex Pharma, and Hevat Biologics

PR Newswire June 27, 2016

Heat Biologics Presents a Poster on its HS-110/Nivolumab Combination Phase 1b Non-Small Cell Lung Cancer Trial at ASCO Annual Meeting

GlobeNewswire June 6, 2016

Why Biotech Stocks Fascinate Investors? - Synta Pharma, CTI BioPharma, Lpath, and Heat Biologics

PR Newswire May 27, 2016

Heat Biologics Reports First Quarter 2016 Financial Results

GlobeNewswire May 11, 2016

Nabriva to Present at the UBS Global Healthcare Conference

GlobeNewswire May 11, 2016

Heat Biologics to Present at PIONEERS 2016, Presented by Joseph Gunnar & Co.

GlobeNewswire April 26, 2016

Heat Biologics Appoints Dr. John Prendergast to Board of Directors

GlobeNewswire April 25, 2016

Heat Biologics and OncoSec Present Data at the American Conference for Cancer Research (AACR) Annual Meeting

GlobeNewswire April 18, 2016

OncoSec and Heat Biologics Present Data at the American Conference for Cancer Research (AACR) Annual Meeting

PR Newswire April 18, 2016

Heat Biologics to Present at the American Association for Cancer Research (AACR) Annual Meeting

GlobeNewswire April 12, 2016

Heat Biologics Announces Cost-Saving Measures and Focused Corporate Strategy to Achieve Important Clinical Milestones

GlobeNewswire April 7, 2016

Heat Biologics to Participate in the 6th Annual Cancer Immunotherapy: A Long-Awaited Reality Conference

GlobeNewswire March 30, 2016

Heat Biologics Announces Closing of Public Offering

GlobeNewswire March 23, 2016

These Penny Stocks to Watch Should Be On Your List Friday 3/18/2016, If You Choose

Accesswire March 18, 2016

Heat Biologics Announces Public Offering of Common Stock and Warrants

GlobeNewswire March 18, 2016

Penny Stocks to Buy on St. Patrick's Day... If You So Choose

Accesswire March 17, 2016

Heat Biologics' CSO to Participate in the 27th Annual Cancer Progress Conference by Defined Health

GlobeNewswire March 9, 2016